The supply of medicine as a strategic product in healthcare is a top priority. Pharmaceutical companies, major players of the drug supply chain, are subjected to many risks. These risks interrupt the supply of medicines in many ways such as their quantity, quality, safety, and their delivery to the right place, right customers, and the right time. Therefore, risk identification and mitigation in the supply process of pharmaceutical companies are highly recommended. Most risks in the pharmaceutical supply chain are internal risks due to the processes, people, technology, and function mismanagement, which could be organized by suitable mitigation strategies.
Global Regulated Authorities have implemented a risk-based approach to the inspection of pharmaceutical operations as a key element including supply processes. The Pharmaceuticals industry, therefore, is expected to take overall responsibility for the quality of its output and also its ability to move materials, components, and the finished products in a timely and efficient manner which ultimately delivers the benefits like reducing the cost of manufactured products, improving access to advanced technologies of life-saving medicines, opening new markets and new business opportunities for manufacturers.
Risk management plays a vital role in the supplier selection, approval, transport, logistics, and management process for assuring the quality and continuity of the supply of medicines. Risks are part of life, but it is crucial that processes are in place to identify and manage them in such a way that the patients and healthcare professionals can continue to enjoy a reliable supply of safe and effective medicines.
OR Scan to QR Code
